14 12 November 2024 false false false false false false false false false false true false false true false true true No description of principal activity 2023-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 2,233 836 3,069 xbrli:pure xbrli:shares iso4217:GBP 08341597 2023-04-01 2024-03-31 08341597 2024-03-31 08341597 2023-03-31 08341597 2022-04-01 2023-03-31 08341597 2023-03-31 08341597 2022-03-31 08341597 core:LandBuildings core:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 08341597 core:FurnitureFittings 2023-04-01 2024-03-31 08341597 core:MotorVehicles 2023-04-01 2024-03-31 08341597 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 08341597 bus:Director1 2023-04-01 2024-03-31 08341597 core:WithinOneYear 2024-03-31 08341597 core:WithinOneYear 2023-03-31 08341597 core:LandBuildings core:OwnedOrFreeholdAssets 2023-03-31 08341597 core:FurnitureFittings 2023-03-31 08341597 core:MotorVehicles 2023-03-31 08341597 core:LandBuildings core:OwnedOrFreeholdAssets 2024-03-31 08341597 core:FurnitureFittings 2024-03-31 08341597 core:MotorVehicles 2024-03-31 08341597 core:DeferredTaxation 2023-04-01 2024-03-31 08341597 core:ShareCapital 2024-03-31 08341597 core:ShareCapital 2023-03-31 08341597 core:SharePremium 2024-03-31 08341597 core:SharePremium 2023-03-31 08341597 core:RetainedEarningsAccumulatedLosses 2024-03-31 08341597 core:RetainedEarningsAccumulatedLosses 2023-03-31 08341597 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 08341597 core:AcceleratedTaxDepreciationDeferredTax 2023-03-31 08341597 core:LandBuildings core:OwnedOrFreeholdAssets 2023-03-31 08341597 core:FurnitureFittings 2023-03-31 08341597 core:MotorVehicles 2023-03-31 08341597 core:DeferredTaxation 2023-03-31 08341597 core:DeferredTaxation 2024-03-31 08341597 bus:SmallEntities 2023-04-01 2024-03-31 08341597 bus:Audited 2023-04-01 2024-03-31 08341597 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 08341597 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08341597 bus:FullAccounts 2023-04-01 2024-03-31 08341597 bus:OrdinaryShareClass1 2024-03-31 08341597 bus:OrdinaryShareClass1 2023-03-31 08341597 core:ComputerSoftware 2023-04-01 2024-03-31
COMPANY REGISTRATION NUMBER: 08341597
Nishkam Pharmacy Limited
Filleted Financial Statements
31 March 2024
Nishkam Pharmacy Limited
Statement of Financial Position
31 March 2024
2024
2023
Note
£
£
Fixed assets
Tangible assets
6
63,577
62,596
Current assets
Stocks
49,181
47,281
Debtors
7
203,390
194,829
Cash at bank and in hand
116,802
222,474
---------
---------
369,373
464,584
Creditors: amounts falling due within one year
8
177,784
175,153
---------
---------
Net current assets
191,589
289,431
---------
---------
Total assets less current liabilities
255,166
352,027
Provisions
9
3,069
2,233
---------
---------
Net assets
252,097
349,794
---------
---------
Capital and reserves
Called up share capital
12
1
1
Share premium account
13
151,312
151,312
Profit and loss account
13
100,784
198,481
---------
---------
Shareholder funds
252,097
349,794
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of directors and authorised for issue on 12 November 2024 , and are signed on behalf of the board by:
S S Sandhu
Director
Company registration number: 08341597
Nishkam Pharmacy Limited
Notes to the Financial Statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 21 Soho Road, Handsworth, Birmingham, B21 9SN.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a small entity as defined in FRS102 and section 382 of the Companies Act 2006 and has taken advantage of the disclosure exemptions available under paragraph 1A.7 of FRS102.
Revenue recognition
Turnover arrives from the sale of preparing, dispensing and reviewing of drugs and other clinical service. Turnover is recognised at the fair value of considerations at point of sale.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Computer software
-
evenly over its estimated useful life of nil years
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Freehold property
-
4% straight line
Fixtures and fittings
-
15% reducing balance
Motor vehicles
-
15% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 14 (2023: 10 ).
5. Intangible assets
Computer software
£
Cost
At 1 April 2023 and 31 March 2024
20,006
--------
Amortisation
At 1 April 2023 and 31 March 2024
20,006
--------
Carrying amount
At 31 March 2024
--------
At 31 March 2023
--------
6. Tangible assets
Freehold property
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
Cost
At 1 April 2023
85,492
20,008
9,682
115,182
Additions
6,831
6,831
--------
--------
-------
---------
At 31 March 2024
85,492
26,839
9,682
122,013
--------
--------
-------
---------
Depreciation
At 1 April 2023
34,652
12,548
5,386
52,586
Charge for the year
3,420
1,786
644
5,850
--------
--------
-------
---------
At 31 March 2024
38,072
14,334
6,030
58,436
--------
--------
-------
---------
Carrying amount
At 31 March 2024
47,420
12,505
3,652
63,577
--------
--------
-------
---------
At 31 March 2023
50,840
7,460
4,296
62,596
--------
--------
-------
---------
7. Debtors
2024
2023
£
£
Trade debtors
99,345
132,765
Amounts owed by group undertakings
80,662
Prepayments and accrued income
1,368
1,518
Other debtors
22,015
60,546
---------
---------
203,390
194,829
---------
---------
8. Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
134,658
153,931
Amounts owed to group undertakings
10,000
Accruals and deferred income
29,669
21,085
Social security and other taxes
2,718
137
Other creditors
739
---------
---------
177,784
175,153
---------
---------
9. Provisions
Deferred tax (note 10)
£
At 1 April 2023
2,233
Additions
836
-------
At 31 March 2024
3,069
-------
10. Deferred tax
The deferred tax included in the statement of financial position is as follows:
2024
2023
£
£
Included in provisions (note 9)
3,069
2,233
-------
-------
The deferred tax account consists of the tax effect of timing differences in respect of:
2024
2023
£
£
Accelerated capital allowances
3,069
2,233
-------
-------
11. Employee benefits
Defined contribution plans
The amount recognised in profit or loss as an expense in relation to defined contribution plans was £ 4,274 (2023: £ 2,835 ).
12. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
1
1
1
1
----
----
----
----
13. Reserves
Share premium account - This reserve records the amount above the nominal value received for shares sold, less transaction costs. Profit and loss account - This reserve records retained earnings and accumulated losses.
14. Summary audit opinion
The auditor's report dated 12 November 2024 was unqualified .
The senior statutory auditor was Hannah Justice FCA FCCA , for and on behalf of BSN Associates Limited .
15. Related party transactions
During the year the following connected parties and transactions were identified: Nishkam Healthcare Trust Nishkam Pharmacy is a 100% owned subsidiary of Nishkam Healthcare Trust. Guru Nanak Nishkam Sewa Jatha (Birmingham) UK An unincorporated charity in which the trustee Mohinder Singh Ahluwalia and J PS Chandan were trustee. Nishkam Healthcare Trust operates from premises at 21 Soho Road, a freehold held by Guru Nanak Nishkam Sewak Jatha (Birmingham) UK. Nishkam Dental Care Limited A 100% subsidiary of Nishkam Healthcare Trust. Nishkam Civic Association A charity in which the trustee Mohinder Singh Ahluwalia, P S Jhutti and J P S Chandan were trustees. Nishkam Security Limited A 25% owned subsidiary of Nishkam Healthcare Trust. Nishkam School Trust A charity in which the trustee Mohinder Singh Ahluwalia was the patron. NPVR Limited A 100% owned subsidiary of Nishkam Healthcare Limited. Sangat Trust A charitable company and its subsidiaries in which Trustee Mohinder Singh Ahluwalia has been a trustee. During the year the company made sales to the following related parties:
2024 2023
£ £
Guru Nanak Nishkam Sewak Jatha (Birmingham) UK 7,519 7,451
Nishkam Healthcare Trust 204 582
Nishkam School Trust 1,931 856
NPVR Limited 7,515
Nishkam Dental Care Limited 14
During the year the company made the following purchases from related parties:
2024 2023
£ £
Nishkam Healthcare Trust 1,304 2,669
During the year the company purchased the following services from related parties:
2024 2023
£ £
Nishkam Healthcare Trust 12,000 12,000
During the year the company made the following donations to related parties:
2024 2023
£ £
Nishkam Healthcare Trust 24,000 318,700
The following amounts were due from related parties:
2024 2023
£ £
Nishkam School Trust 379
Nishkam Healthcare Trust 1,500
NPVR Limited 79,162
The following amounts were due to related parties:
2024 2023
£ £
Nishkam Healthcare Trust 22,375 12,375
16. Controlling party
The ultimate controlling party is Nishkam Healthcare Trust, who own 100% of the share capital of Nishkam Pharmacy Limited .